Literature DB >> 27230053

Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.

David M Kaye, Shane Nanayakkara, Donna Vizi, Melissa Byrne, Justin A Mariani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27230053     DOI: 10.1016/j.jacc.2016.03.539

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  15 in total

1.  Left ventricular vortex and intraventricular pressure difference in dogs under various loading conditions.

Authors:  Katsuhiro Matsuura; Kenjirou Shiraishi; Kotomi Sato; Kazumi Shimada; Seijirow Goya; Akiko Uemura; Mayumi Ifuku; Takeshi Iso; Ken Takahashi; Ryou Tanaka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-08       Impact factor: 4.733

Review 2.  Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Authors:  Rima Kamel; Jérôme Leroy; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  Nat Rev Cardiol       Date:  2022-09-01       Impact factor: 49.421

Review 3.  Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.

Authors:  Marat Fudim; David M Kaye; Barry A Borlaug; Sanjiv J Shah; Stuart Rich; Navin K Kapur; Maria Rosa Costanzo; Michael I Brener; Kenji Sunagawa; Daniel Burkhoff
Journal:  J Am Coll Cardiol       Date:  2022-05-10       Impact factor: 27.203

Review 4.  Imaging and Management of Heart Failure and Preserved Ejection Fraction.

Authors:  Fernando Telles; Thomas H Marwick
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-09-27

5.  Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials.

Authors:  Ravi B Patel; Sanjiv J Shah
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-10-08       Impact factor: 13.820

Review 6.  Cellular and molecular pathobiology of heart failure with preserved ejection fraction.

Authors:  Sumita Mishra; David A Kass
Journal:  Nat Rev Cardiol       Date:  2021-01-11       Impact factor: 49.421

Review 7.  Management of heart failure with preserved ejection fraction.

Authors:  Emma Gard; Shane Nanayakkara; David Kaye; Harry Gibbs
Journal:  Aust Prescr       Date:  2020-02-03

8.  Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction.

Authors:  Shane Nanayakkara; Melissa Byrne; Vivian Mak; Kaye Carter; Eliza Dean; David M Kaye
Journal:  J Am Heart Assoc       Date:  2020-06-18       Impact factor: 5.501

9.  Old Drug, New Trick? Oral Milrinone for Heart Failure With Preserved Ejection Fraction.

Authors:  Daniel N Silverman; Brian A Houston; Ryan J Tedford
Journal:  J Am Heart Assoc       Date:  2020-06-18       Impact factor: 5.501

Review 10.  Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.

Authors:  Michael E J Preedy
Journal:  Cardiovasc Drugs Ther       Date:  2020-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.